Le fonds français dédié aux start-up studios The French Tech Acceleration team within BPI France’s Innovation Division is dedicated to investing in start-up support structures such as accelerators and startup studios. Our current strategy is to primarily focus on supporting start-up studios initiatives, especially those operating in deeptech sectors (Greentech, Medtech, Biotech, Cybersecurity, Quantum systems etc...) which require significant capital needs. Deeptech startup studios aim to create high potential start-up developing disruptive technologies mainly resulting from the research work of public laboratories. In addition, we also support other growth sectors like construction sector, industry 4.0 or e-health. With 300M€ under …

Type: NGO, Think-tanks, Ed, & Culture Activities: it services

At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, cardiovascular, and vision, we design healthcare solutions that are smarter, less invasive and more personalized. We are developing the next generation of med tech solutions to tackle the most pervasive and complex health challenges for people around the world.

Type: Large company

1st economic magazine in the region. Founded in 1983, Entreprises Occitanie covers regional economic news by highlighting all sectors of activity. Designed by a team of professional journalists and published by Medef 31, this monthly is available in 10 issues, supplemented by the Top Economique Occitanie which lists more than 10,000 decision-makers in the region. Reports, portraits of entrepreneurs and the calendar of the main events are regularly published on the web. aeronautics, agri-food, space, innovation, finance, employment/training, health, and construction

Type: Media

The data scientists club datacraft allows an exchange of best practices between data experts. It is a unique Club model, inspired by companionship, and designed to allow data scientists/data engineers to train among peers and enable companies to accelerate their AI/data projects. Access to the Club is through an annual membership.

Type: Startup Activities: edtech it services Technologies: A.I. A.I. - Machine Learning Data Analytics

The conviction that, in the “common good”, the greatest good is first and foremost what is common to us. Bien Commun Advisory is a consulting firm in communications strategy, economic information, public affairs and media relations. Founded by Antoine Boulay in 2019, it now has around fifteen employees and operates for large companies, SMEs, start-ups, federations and players in the associative world.

Type: SMB Activities: consulting

Now part of Precision IO Groupe, Quantum Surgical is a company speacializing in medical robotics and AI. Its Epione® robotic percutaneous ablation platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. More than 1,400 of patients have already been treated worldwide. Co-founded in 2017 and with a team of 140+ employees, Quantum Surgical is headquarted in Miami, Florida, with offices in Montpellier, France. Quantum Surgical received the Prix Galien USA in …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Robotics A.I.

At Okeiro, we develop precision medicine solutions that transform the monitoring of transplant patients and those with chronic conditions. Our predictive algorithms, scientifically validated digital biomarkers, convert complex medical data into information directly usable by healthcare teams. This technology allows us to: - Detect early signals of complications or graft rejection - Personalize each treatment for truly proactive care - Intervene before critical symptoms appear Our goal is clear: to tangibly improve patients' lives by equipping healthcare professionals with innovative tools that make a daily difference. In close collaboration with healthcare professionals and pharmaceutical companies, we accelerate the clinical validation …

27 similar entities Type: Startup Activities: healthtech Technologies: A.I. A.I. - Machine Learning

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or patientinfo@gene.com. Community Guidelines: 1. We want to foster …

Type: Large company

The Il Sole 24 ORE Group is the main multimedia publishing group active in Italy in the economic, financial, professional and cultural information and training sector and the first Italian publishing center to have a complete multimedia information platform, equipped with all the main means of dissemination: newspaper, periodicals, digital platforms, news agency, radio, events and TV. The information offer of the Sole 24 Ore, a leading daily newspaper in economic, financial and regulatory information directed by Fabio Tamburini - are the Radiocor press agency (Italian leader in financial information), the portal www.ilsole24ore.com, Radio 24, the news&talk radio station, founded …

Tags: H2020 Type: Media

Thanks to its rich collection of more than 15,000 works, the Paris Museum of Modern Art is one of the largest museums of modern and contemporary art in France. Its permanent collections present the major artistic movements from the 20th century to the current scene, illustrated by major artists in the history of art: Picasso, Dufy, Modigliani, Derain, Picabia, Chagall, but also Christian Boltanski, Philippe Parreno and Peter Doig. The museum also has rare and exceptional in situ works such as the first two versions of La Danse by Matisse produced in 1932 and 1931-1933 and La Fée Electricité by …

Type: NGO, Think-tanks, Ed, & Culture Activities: arttech

UroMems is a biotechnology company based out of 5, rue Raymond Chanas, 38320, Eybens, FRANCE Urologie and Dispositifs médicaux

Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models

51 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I.

The movement of professionals in the health sector Our mission? Federate the health ecosystem. French Care is the movement of all professionals in the health sector, it is supported by Bpifrance and the Acteurs de la French Care association, which brings together private and public players in the health sector in France. French Care serves the development of ecosystems and excellence in the service of the patient. The mission of La French Care: to promote and develop excellence in health in France.

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Plant engineering for a better world Plant engineering for a better world

Type: Startup Activities: cleantech greentech Technologies: Bio sourced materials

Explore the CNN archives with CNN Collection, home to exclusive footage from the biggest global and local news stories. CNN Collection, the content licensing division of CNN, is a premier provider of footage, audio, and stills for film, television, advertising, and institutional production companies. With over 600,000 assets available online and over 4 million assets in the CNN archives, CNN Collection offers a library of unparalleled scope, including politics, entertainment, crime, b-roll, and historic coverage. As the exclusive source for CNN branded content, CNN Collection proudly features CNN’s world-renowned talent, including Anderson Cooper, Larry King, Dr. Sanjay Gupta, Wolf Blitzer, …

Type: Media

Transforming science into life-changing treatments for people living with rare diseases and drug-resistant infections. LifeArc® is a self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections. We aim to deliver this by conducting and funding pioneering research, and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments. Our vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster. We have been doing this for more than 25 years and our work has resulted …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center …

Type: Large company

LeMonde.fr has been present on the Internet since December 19, 1995, 51 years to the day after the creation of the paper newspaper. The site and its mobile applications are among the most consulted in France to follow news in real time (international, economy, politics, society, etc.) Leading news website in French. Journalism, Media, Online Press, Written Press, Internet, Video, and Ethics

Type: Media

We back and partner with game-changing technology and healthcare companies in Europe, India, China, Japan and the US. Eight Roads Ventures is a global venture capital firm backed by Fidelity that helps entrepreneurs scale. We partner with game-changing technology and healthcare companies with a presence in Europe, India, China, Japan and the US. Our global platform has 50+ years of venture investing experience, $5Bn+ in AUM, over 350 portfolio companies and 35+ IPOs. Healthcare, Biosciences & Life Sciences, Consumer Technology, Internet & e-Commerce, FinTech & FinServ, Telecommunications, Food & Agriculture, Education and Skills Development, Enterprise Tech, Pharmaceuticals, Edu Tech, Health …

Type: Incubators & VCs

We create the first closed-loop AI generative biology company to create the new standard of biology reasoning Owkin is building the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation, while reshaping how humanity understands and engineers biology. Like other frontier AI companies, we believe the leap from narrow tools to true reasoning systems marks the start of a new era — where intelligence is not just assisting scientists but autonomously advancing discovery. Owkin’s moats are structural and compounding. We are creating the only large-scale reasoning model trained natively on patient-level multimodal data and reinforced through real biological feedback …

Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. A.I. - Machine Learning A.I. - Natural Language Processing Data Analytics Generative A.I.

Bringing microbiomics to the clinic GMT Science is an innovative medtech company harnessing standardized, high-resolution stool metagenomics and AI-driven data science to develop in vitro diagnostics (IVD), brought to clinicians via medical laboratories. ​ It brings together a multidisciplinary team of microbiome experts, clinicians, AI specialists, data scientists and medical software engineers to develop in vitro diagnostics leveraging the gut microbiome.​ GMT Science has developed BiomScope®, a proprietary CE-marked IVD software to accurately measure microbial species, genes and functions, outperforming reference metagenomics pipelines.​ Its first product, IOScope®, is an in vitro diagnostics predicting the response to immune checkpoint inhibitors (ICI). …

6 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: A.I.

Together, let's light up the night against illness and for all sick people! Created in 2010, the Race of Lights is a national awareness event around the fight against disease. Since its creation, more than one million euros have been collected for the benefit of health organizations (foundations, hospitals, patient associations, etc.). Accessible to all, the event brings together more than 15,000 participants and 200 companies each year. Each participant, runner or walker, symbolically carries a luminous object to “light the night against illness and for all sick people”. solidarity, sport, running, walking, and team-building

Type: Event

Rebrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated.

Type: Startup Activities: deeptech healthtech biotech Technologies: A.I. Data Analytics

We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze.

Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology

For the most enterprising founders. From seed through growth, Salesforce Ventures provides the most enterprising founders with the patient capital, coveted community, and unique access to the resources they need to build industry-defining companies. Since 2009, we’ve partnered with over 700 of the world’s most tenacious enterprise software companies, deployed over $6B in capital, and guided more than 200 portfolio companies to IPOs and acquisitions. Notable investments include: Anthropic, Box, Cohere, DocuSign, Fal, LiveKit, Lovable, Runway, Snowflake, Twilio, Vercel, Wiz, and Zoom. Salesforce Ventures leverages decades of expertise in the cloud and long-term relationships with key decision-makers at thousands of …

19 similar entities Type: Startup Activities: it services Technologies: SaaS

Smarter proteins for a sustainable future. By 2050, the world's population will surpass 10 billion people. To feed the current population and future generations we need to address global food challenges, today. How can we solve this problem without overwhelming the planet? And how can we deliver higher quality, more nutritious food for everyone? With Protera’s Natural IntelligenceTM technology, we believe the future is already here. Protera’s technology uses predictive algorithms that calculate millions of amino acid combinations and simulate protein patterns in a matter of seconds. Our technology is based in Deep Learning and allows us to shine a …

Type: SMB Activities: it services Technologies: A.I. A.I. - Deep Learning

We create vibrant places and thriving cities through workspace, retail and leisure. Workspace | Laboratories | Retail | Leisure We own, let and manage outstanding buildings, workspace, innovation and science facilities. Our purpose: creating thriving cities. This purpose fuels our passion for supporting arts and culture, our deep community engagement and our ambitious plans for future growth. It ensures every investment and decision we make benefits our customers, our communities and our colleagues: because when our cities thrive, so do we. Our commitment to creating thriving cities has helped us to grow into a company with more than £1bn in …

19 similar entities Type: SMB Activities: proptech

Making Bio The New Normal We are on a mission to make bio the new normal. World Bio Markets Ltd is the owner of three market leading events dedicated to driving the commercialization of the global industrial biomanufacturing sector and the world's only dedicated news website for the bioeconomy. Operating across Europe, North America and Asia, our Bio Innovations series events facilitate commercial connections and generate deal flow between bio-developers and producers, global brands and buyers, community enablers, investors and financiers and suppliers. Our commercially-focused format has facilitated thousands of pre-arranged meetings and been the catalyst for multiple new collaborations …

Type: Media

We are contrarian. We are bold. We are imaginative risk takers. Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.

Type: Incubators & VCs

Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.

260 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

At BT, we deliver the connectivity, security and expertise that power modern British life. As the digital backbone of Britain, we support the systems, services and institutions the nation relies on every day– the trusted networks that millions of people depend on. Our purpose is simple: we connect for good. Because when connections work, there are no limits to what people can do. As technology continues to shape how we live, work and play, the role of connection has never been more important. Through the power of technology, we’re helping our customers – and the nation –thrive in a digital …

Type: Large company Technologies: SaaS

Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully …

60 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Casdin Capital is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. As we push into new markets and new developments, we stick to our core …

Type: Incubators & VCs

Turning chemistry circular ChainCraft develops and exploits proprietary fermentation processes to produce biochemicals from organic waste. The first product range, Medium Chain Fatty Acids (MCFA), can be used in existing and new applications in animal feed, lubricants, plasticizers, polymers, coatings and flavours and fragrances. The main product, the C6 fatty acid Caproic Acid, can serve as an important intermediate for a C6 chemistry platform. ChainCraft uses open mixed culture fermentation as technology. This non-GMO, non-sterile, continuous type fermentation leads to several operational and cost advantages. Due to the nature of the technology, a wide range of low grade feedstocks like …

Type: Startup Activities: deeptech greentech Technologies: Bio sourced materials

Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, …

4 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics

12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne), around Gustave Roussy, the first cancer center in Europe. Its objective is to bring together all the talents (health professionals, researchers, students, businesses) and citizens concerned by the disease to become an international reference site in innovation in health and oncology. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, medtech and e-health. http://www.cancer-campus.com/le-programme-onco-entrepreneur/ - the …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech

Accelerating Innovation Against Cancer The Paris Saclay Cancer Cluster (PSCC) is building a world-class biocluster to position France as the leading hub for cancer innovation. Selected by the French authorities as part of the Healthcare Innovation 2030 plan, the PSCC is a non-profit French Foundation for Scientific Cooperation (FCS) with a dual global ambition: ✅ Change the outcome of millions of patients fighting cancer worldwide ✅ Position France and Europe at the forefront of the 1st pharmaceutical industry A world-class ecosystem driving innovation Founded by Gustave Roussy, Sanofi, Inserm, Paris-Saclay University, and the Polytechnic Institute of Paris, the PSCC has …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech

Le media de référence des professionnels de la finance A PROPOS DU GROUPE OPTION FINANCE Avec ses différentes publications, le Groupe Option Finance est le seul groupe de presse à destination de l’ensemble des professionnels de la finance, de l'assurance et du droit des affaires. L’hebdomadaire Option Finance, se présente comme un véritable trait d’union entre les entreprises et la communauté financière depuis plus de 20 ans. Dédié à la présentation et l’analyse des grandes évolutions de la finance, aux innovations et montages financiers, aux problématiques de gestion des entreprises ainsi qu’à l’actualité de la communauté financière et de la …

Type: Media

Giving Life to Science PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders. For more information, visit www.puretechhealth.com or connect with us …

84 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Coave therapeutics Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success …

80 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Sacropelvic Solutions SI-BONE® is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. SI-BONE developed an innovative, patented implant to fuse the SI joint. The iFuse Implant System® provides a less invasive alternative to traditional sacroiliac (SI) joint fusion surgery and has been used in over 65,000 procedures to date. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For additional information on the company or the products including risks and benefits, please visit …

Type: Startup Activities: healthtech deeptech Technologies: Cybersecurity

Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to expertise, technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, drug research, and Neuroscience

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech Technologies: Synthetic Biology Data Analytics

🚀 Powering startups | #4YFN26 🚀 At 4YFN, we fuel the startup journey by boosting new ventures with contacts, exposure, and investments throughout their life cycle. As the event partner of MWC Barcelona—the world’s largest and most influential connectivity event—4YFN brings together all the key players needed for a successful digital startup. This includes investors, corporate innovators, and influential decision- makers such as CEOs from global mobile operators and frontier tech companies. Our event not only connects startups with these vital players but also propels them onto the radar of industry leaders. This support helps new business ventures gain the …

Type: Incubators & VCs

Focused on generating precision medicines by leveraging the power of single-cell technologies One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.

57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension.

Type: Startup Activities: deeptech healthtech

Empowering the Surgeon Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. medical device, minimally invasive surgery, digital surgery, comanipulation, AI, Machine Learning, Surgery, Laparoscopy, and Surgical Robotics

80 similar entities Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning Robotics A.I. - Image Processing

Formerly Umiami | The tender, juicy whole filet made from plants. We make delicious, clean-label meat replacements from plants. Our first product, SWAP Filet (SWAP Chicken in the United States) is a thick, whole filet that closely replicates the taste, texture and appearance of chicken using a short list of familiar ingredients. From preparation to performance, SWAP Filet can replace chicken on any menu, enabling chefs to recreate classic recipes for modern times. Originally founded in France in 2020, we rebranded from Umiami to SWAP in 2024 to convey how simple it is for consumers and chefs to swap protein. …

Tags: FrenchTech120 Type: Startup Activities: foodtech manufacturing Technologies: Synthetic Biology

A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Diagnose Better. Treat Smarter. MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making. Microsatellite Instability, Next-Generation Sequencing, …

Type: Startup Activities: healthtech Technologies: Data Analytics

Nouvelles solutions nutritionnelles pour réduire la prise de poids corporel humaine et animale The Company’s proprietary platform targets fat taste receptors (CD36 and GPR120) — a novel mechanism that naturally stimulates the body’s endogenous release of satiety hormones including GLP-1, CCK, and PYY, without the need for exogenous hormone administration. This approach directly addresses the key limitations of current GLP-1 therapies: weight rebound after discontinuation, loss of lean muscle mass, and gastrointestinal side effects. Preclinical data demonstrate up to 40% reduction in food intake in obese animal models and 50% reduction in post-semaglutide weight rebound. Clinical data from 87+ subjects …

Type: Startup Activities: foodtech Technologies: Data Analytics

You're Good, get Better. PE Cube is a SaaS solution for each team member of Private Equity management companies to optimize fund management’s performance and Investor Relation while enabling a rich, reliable and transparent communication towards each of its stakeholders. PE Cube is based on 20 years of Private Equity practice and on the key-belief that data is crucial to each level of fund management. This is why PECube is designed to ensure flawless end-to-end processing to express the full potential for monitoring and steering fund management activity. Each general partner member is thus equipped to ensure reliability, security and …

Type: Startup Activities: it services Technologies: SaaS

A leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies. Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. CIC currently manages over £500 million and has invested in 30+ companies. We invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics. IP Commercialisation, Venture Capital, healthcare, …

Type: Incubators & VCs

Where Design meets Biology. Where Design Meets Biology. Design, Biofabrication, Consulting, Education, Biotechnology, Material Innovation, New Materials, and Sustainability

Type: Startup Activities: civictech cleantech greentech Technologies: New Materials

The 100% economy chain The 100% economy chain

Type: Media Startup Activities: media Technologies: IoT

The UK's trade body for EIS and SEIS - the Enterprise Investment Scheme and Seed Enterprise Investment Scheme The UK's trade body for EIS and SEIS - the Enterprise Investment Scheme and Seed Enterprise Investment Scheme. EISA is a highly effective not for profit organisation which exists to aid the provision of capital to UK small and medium-sized enterprises (SMEs) through the Enterprise Investment Scheme (EIS) and the Seed Enterprise Investment Scheme (SEIS). EISA works closely with HM Treasury, HM Revenue and Customs, Government Ministers, MPs and the FCA to enhance the EIS and promote the benefits of the scheme …

Type: NGO, Think-tanks, Ed, & Culture Activities: fintech

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation. Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people. Attorney Advertising: This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you and Cooley LLP, Cooley (UK) LLP, Cooley SG LLP, Cooley HK or any other Cooley entity (collectively referred to as “Cooley”). By reviewing this content, you agree that the information provided does not constitute …

Type: Large company

Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

First in business in Italy and in the world Class CNBC is the first Italian channel dedicated to business and finance. Live every day, from the closing of the Asian stock markets to the final bell on Wall Street, it is the television of business and savings, of the markets and the global economy, but also of companies and professionals. Through authoritative information, simple language, Class CNBC is the essential tool for those who want to invest informed, for those who have to make decisions at work and is the channel that business leaders use to communicate to the market. …

Type: Startup Activities: fintech

United against brain cancer 🌟 Stars in the Sea – Beat Glioblastoma Faced with glioblastoma, never give up. Stars in the Sea is a national association dedicated to the fight against glioblastoma, the most aggressive of brain tumors. Since 2019, we have united researchers, caregivers, families and volunteers around the same conviction: hope is born from collective action. 🎗️ Our three missions: 1️⃣ Fund research to bring out new therapeutic strategies and accelerate discoveries. 2️⃣ Support patients and their loved ones, by breaking isolation and offering listening, help and support throughout the journey. 3️⃣ Raise awareness and mobilize, to raise …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

When science undertakes. The community that brings together deeptech players for an entrepreneurial, collective and scientific response to our contemporary challenges

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Interdisciplinary Thematic Institute of the University of Strasbourg The Strasbourg Medicines Institute responds to the challenges of the medicines sector: producing cutting-edge research up to the pre-clinical stage, promoting technological innovation through the creation of start-ups and training the new generation of researchers in the management of medicines innovation.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Groupe STRATOS is an entrepreneurs community with advisory services and build-up activities Groupe STRATOS is an entrepreneurs community with advisory services and build-up activities. Groupe STRATOS was founded in 2020 with the merger of 2 other companies created 10 & 20 years ago. We provide companies with M&A services and we also yearly invest into companies as private equity player. Contact us : entrepreneurs@groupe-stratos.com Our website : www.groupe-stratos.com

Type: Incubators & VCs

Built on excellence. Driven by change. Mintz is a full-service law firm serving clients in the life sciences, energy, private equity, and technology industries. The world’s most innovative companies trust Mintz to accelerate their business, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. Careers: www.mintz.com/careers This page may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this page does not constitute a client/attorney relationship. Antitrust & Federal, Bankruptcy, Communications, Consumer Products, Corporate & Securities, Energy & Clean Tech, Environmental, Government, Health, Immigration, IP, International, Litigation, Private Client, Public …

Type: Large company

The Hub team supports the development of startups invested by Bpifrance venture capital funds. Bpifrance Le Hub is the operational partner of startups and scaleups invested by Bpifrance’s venture capital innovation investment funds. The team of 30 professionals at Bpifrance Le Hub dedicates itself daily to its mission: contributing to the development and growth of all Bpifrance investments. It offers them tailor-made support, whatever their business needs or the progress of their development. The Hub makes the skills of its teams available to startups by offering them a range of services and advice: - operational support for managers via sourcing …

Type: Public

Varenne Capital Partners is a Paris-based, process-driven, global investment manager whose purpose is to deliver superior long-term returns with the minimum necessary risk-taking. We strive to achieve this goal by employing proprietary research and combining complementary investment frameworks in a single strategy: Long Equity, Short Equity, Merger Arbitrage and Tail Risk Hedging. Our ‘brokers are not welcome’ policy means that we rely exclusively on our own internal research and base our analysis on facts and figures. All of our investment frameworks stem from years of research and development and as a result comprise original methodologies, formalized processes, dedicated teams of …

Type: Incubators & VCs

Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products.

7 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: five instruments, the ATxTM, STxTM, GTxTM, DTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software …

337 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT, a BCorpTM certified company since 2025, is a biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

TechCrunch, founded on June 11, 2005, is a news website dedicated to the tech scene. We provide breaking technology news, opinions, and analysis on tech companies from around the world. From publicly traded tech companies to emerging startups and venture capital funding rounds, TechCrunch is your number one guide for all things startups. blogging, startups, tech, technology, VC, venture capital, entrepreneurs, founders, and investors

Type: Large company Activities: it services

We are bringing a modern approach to the treatment of PCOS with our AnaviTM System. May Health, formerly AblaCare, is developing a modern approach to PCOS.

Type: Startup Activities: deeptech healthtech

Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through …

100 similar entities Type: Startup Activities: fintech Technologies: Data Analytics A.I. A.I. - Natural Language Processing A.I. - Machine Learning

This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis.

Type: Startup Activities: healthtech

Elicit Plant pioneers phytosterol-based solutions to strengthen crop resilience and boost yields amid climate hazards. ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit …

Tags: FrenchTech120 Type: Startup Activities: agritech cleantech greentech water management Technologies: Decarbonization

Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins.

110 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials

Rothschild & Co is one of the world's largest independent financial advisory groups. We offer a distinct perspective that makes a meaningful difference to our clients’ business and wealth. With a team of over 4,800 talented financial services specialists on the ground in 50 countries across the world, we provide independent advice on M&A, strategy and financing, as well as investment and wealth management solutions to large institutions, families, individuals and governments. As a family-controlled business that has been at the centre of the world’s financial markets for over 200 years, we can rely on an unrivalled network of specialists …

Type: Large company

Contemporary Art Center, Paris📍 With its 22,000 m2, the Palais de Tokyo stands out through its energy as one of the largest contemporary art centers in Europe. It encourages contemporary creation with an eclectic and inventive program around emerging and established artists from all backgrounds. contemporary art, exhibitions, performances, and concerts

Type: NGO, Think-tanks, Ed, & Culture Activities: arttech

Developing a biobased future is our passion. Industrial biotechnology is our business. The BRAIN Biotech Group is a leading company in the research, development and production of specialist enzymes with a focus on the food and life science industries. In addition, the Group develops microbial production organisms and scalable bioprocesses for the economic production of specialty enzymes and other proteins. Customized innovative biological solutions for more sustainable products and processes round off the portfolio. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The business activities of the integrated company are divided into the two segments BRAINBiocatalysts …

60 similar entities Type: SMB Activities: healthtech biotech civictech deeptech Technologies: Batteries Bio sourced materials Synthetic Biology

Find on LesEchos.fr all the economic and financial news in France and around the world, discover exclusive analyses, special reports, decryptions, chronicles and large formats. http://www.lesechos.fr/

Type: Media

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Together for healthy lives in Europe EIT Health promotes entrepreneurship and innovation in healthy living and active ageing, providing Europeans with new opportunities and resources. It enables citizens to lead healthier and more productive lives by delivering products, services and concepts that improve quality of life and contribute to the sustainability of healthcare across Europe. Health Care Administration, Health Consulting, Innovation in Healthy Living and Active Ageing, Sustainability of Healthcare, Acceleration, and Education

Tags: H2020 Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

The monthly magazine for private equity professionals Find the latest news from investment capital professionals on our site and our magazine. Deals, surveys and analyses, with a cumulative audience of more than 30,000 readers, Private Equity Magazine has become for 10 years the reference publication for French and European private equity players.

Type: Media

Interdisciplinary research and education in artificial intelligence In a national and international context of competition in artificial intelligence, SCAI brings together a strategic range of disciplines of modern artificial intelligence in the heart of Paris and in Sorbonne Université Abu Dhabi. The SCAI is a structure of the Sorbonne University Alliance able to federate the communities of the three faculties of Arts & Humanities, Science & Engineering and Medicine of Sorbonne University, as well as members of the Sorbonne University Alliance (UTC, MNHN, INSEAD). A double ambition in both research & education Our goal is to contribute significantly to the …

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

Discover. Target. Cure. Enhanced Genomics is a pioneering functional genomics company harnessing its proprietary 3D genomics technology to transform drug target discovery. By integrating 3D genomics with multi-omics approaches, Enhanced leverages 3D Multi-omics to deliver unparalleled insights into gene regulation and disease mechanisms. This innovative approach accelerates the development of novel therapeutics across a wide range of disease areas.

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We help healthtech startups navigate product development, bringing their innovations to market – and patients – faster. Neighborhood accompanies biotech & medtech startups. We provide personalized mentoring, the expertise of VCLS, and a broad network to: 🔓 unlock your global regulatory strategy, ✅ derisk your product development, and 🧩 build your community. We have a proven track-record of making projects more financeable, thanks to our unique expertise built through close collaboration with regulators and our expansive network of industry actors. Neighborhood boosts startups bringing innovative products to patients. Biotech, Medtech, Regulatory Strategy, Market Access, Product Development, and Derisking

Type: Incubators & VCs

BionomeeX provides innovative analysis tools to support your biological, medical and environmental R&D projects. BionomeeX is a CNRS, and Univ. Montpellier spin off company. Our solutions include, at the same time, crafted algorithms and/or adapted computational solutions in a single package following your needs and demands. We also deploy our own software initially brewed in the academic world to provide solutions in biology, genetics, genomics... Biology, AI, and DeepLearning

23 similar entities Type: Startup Activities: deeptech it services Technologies: A.I.

Trusted adviser to investors worldwide For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best investment ideas are found when a diverse workforce is encouraged to bring forward unique perspectives. Wellington Management is one of the world’s largest independent investment management firms, serving as a trusted adviser to over 2,400 clients in more than 60 countries. We manage more than US$1 trillion for pensions, endowments and foundations, insurers, family offices, fund sponsors, global wealth managers, and other clients. We offer comprehensive …

Type: Large company

Altevax is developing a disruptive immunotherapy technology against cancer Altevax is a Phase 2 clinical-stage biotechnology company developing a pioneering melanin-based immunotherapy platform for cancer treatment. Its patented technology enhances antigen-specific T-cell immune responses and is compatible with a broad range of peptides, with potential to complement existing immuno-oncology approaches, including anti-PD-1 therapies. Altevax’s lead program targeting TERT in glioblastoma is currently in Phase 2 clinical development. The company collaborates with leading clinical institutions, including AP-HP, and is actively fundraising and exploring strategic partnerships to accelerate development. Cancer vaccines, immunotherapy, melanin, therapeutic vaccines, Peptidic vaccines, infectious diseases, CD8 Killer T …

65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Investing in Life. Investing in Science. Investing in Future. Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in …

Type: Incubators & VCs

🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. [join.gourmey.com] GOURMEY is France's pioneering cultivated meat company. 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. > Join.gourmey.com

Type: Startup Activities: cleantech greentech Technologies: Decarbonization

InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the Université́ de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised €4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results …

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

#tech#startups#corporate#IP/IT#social#employment#tax Harlay Avocats (anciennement Kahn & Associés) est un cabinet d’avocats indépendant qui occupe depuis plus de vingt ans une place privilégiée dans le domaine du conseil aux entreprises de croissance et aux investisseurs dans les secteurs des technologies, de l’Internet, de l’e-commerce, des télécommunications, des sciences de la vie et des énergies renouvelables. La très bonne connaissance de ces secteurs d’activité permet au Cabinet d’être régulièrement sélectionné par les acteurs clés de ces domaines pour les assister lors de leurs opérations en France et à l’international. Le Cabinet conseille également les entreprises d’industries plus traditionnelles : presse et media, …

Type: SMB Activities: legaltech

Public affairs - Institutional relations M&M Conseil has specialized in the organization of institutional events and public affairs consulting for more than 25 years. Close to French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations

19 similar entities Type: SMB Activities: consulting

Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology

50 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your key to better care. CONCILIO is revolutionizing healthcare access with its unique MEDICAL CONCIERGE service, which combines cutting-edge technology with a team fully dedicated to the well-being of employees and their families. We support businesses and their employees daily through a wide range of services: doctor recommendations, easy appointment scheduling, teleconsultations, digital health assessments, and preventive programs. Concilio also offers its partners the chance to benefit from its advanced technological expertise through CONCILIO SOLUTIONS. This service enables professionals to innovate, increase profitability, and leverage our proven technologies, teams, and processes. E-santé, Téléconsultation, Recherche de Médecins, Bilan Santé, téléconseil médical, …

Type: Startup Activities: healthtech

Developing therapeutics for diseases with impaired kidney function ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Building new therapies atom by atom. Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new approaches to significantly improve patient outcomes for millions around the world by building new therapies atom by atom. The Nanobiotix philosophy is one rooted in designing pioneer physical-based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. The Nanobiotix global development strategy seeks to address the largest market in oncology—patients who receive radiotherapy as part of their treatment—with NBTXR3 (JNJ-1900). As the first product candidate from the company’s nanoradioenhancer platform, NBTXR3 aims to increase …

Type: SMB Activities: nanotech deeptech biotech Technologies: Synthetic Biology

Building companies of the future Transition is not enough. We require a radical change, we require a transformation to achieve tangible changes in our business and society centered on net zero objective by 2050. We are 25 years from 2050 and any asset or infrastructure invested today will still be in operation by 2050. We can’t dream of a better world. We need to create it by our actions today. We need to disrupt energy in us, our organisations and around us. energy, innovation, startups, decarbonisation, decentralisation, and digitalisation

Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech greentech Technologies: Decarbonization

Making T-Cell Receptor Biologics a Reality T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanized TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs. We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. biotechnology, research, T cell, biologics, and science

104 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The most active venture investor in Norway - Building the Businesses of Tomorrow Investinor is an evergreen investment company funded by the Norwegian government. It invests in promising unlisted (private) companies aiming for international growth and expansion. Investinor manages NOK 4.2 billion (mEuro 525) and invests on the same terms and conditions as private investors, with a clear exit strategy for all investments. Investinor is one of the major venture investment companies in Norway, both in terms of manpower and capital under management. Our team has a superior overview of the market and attracts high quality dealflow.

Type: Incubators & VCs